title: Key pathways associated with heart failure development revealed by gene networks correlated with cardiac remodeling.
abstract: Heart failure (HF) is the leading cause of morbidity and mortality in the industrialized world. While the transcriptomic changes in end-stage failing myocardium have received much attention, no information is available on the gene expression patterns associated with the development of HF in large mammals. Therefore, we used a well-controlled canine model of tachycardia-induced HF to examine global gene expression in left ventricular myocardium with Affymetrix canine oligonucleotide arrays at various stages after initiation of rapid ventricular pacing (days 3, 7, 14, and 21). The gene expression data were complemented with measurements of action potential duration, conduction velocity, and left ventricular end diastolic pressure, and dP/dt(max) over the time course of rapid ventricular pacing. As a result, we present a phenotype-centered gene association network, defining molecular systems that correspond temporally to hemodynamic and electrical remodeling processes. Gene Ontology analysis revealed an orchestrated regulation of oxidative phosphorylation, ATP synthesis, cell signaling pathways, and extracellular matrix components, which occurred as early as 3 days after the initiation of ventricular pacing, coinciding with the early decline in left ventricular pump function and prolongation of action potential duration. The development of clinically overt left ventricular dysfunction was associated with few additional changes in the myocardial transcriptome. We conclude that the majority of tachypacing-induced transcriptional changes occur early after initiation of rapid ventricular pacing. As the transition to overt HF is characterized by few additional transcriptional changes, posttranscriptional modifications may be more critical in regulating myocardial structure and function during later stages of HF.
authors.affiliation: The Institute for Computational Medicine, The Johns Hopkins University, Baltimore, Maryland 21205, USA.
authors.forename: Zhong
authors.initials: Z
authors.lastname: Gao
authors.forename: Andreas S
authors.initials: AS
authors.lastname: Barth
authors.forename: Deborah
authors.initials: D
authors.lastname: DiSilvestre
authors.forename: Fadi G
authors.initials: FG
authors.lastname: Akar
authors.forename: Yanli
authors.initials: Y
authors.lastname: Tian
authors.forename: Antti
authors.initials: A
authors.lastname: Tanskanen
authors.forename: David A
authors.initials: DA
authors.lastname: Kass
authors.forename: Raimond L
authors.initials: RL
authors.lastname: Winslow
authors.forename: Gordon F
authors.initials: GF
authors.lastname: Tomaselli
mesh_terms: D000200:Action Potentials; D000818:Animals; D004195:Disease Models, Animal; D004285:Dogs; D020869:Gene Expression Profiling; D053263:Gene Regulatory Networks; D006333:Heart Failure / Q000209:etiology / Q000235:genetics* / Q000503:physiopathology; D009206:Myocardium / Q000378:metabolism; D020411:Oligonucleotide Array Sequence Analysis; D015398:Signal Transduction / Q000235:genetics* / Q000502:physiology; D017180:Tachycardia, Ventricular / Q000150:complications; D020257:Ventricular Remodeling / Q000502:physiology*
references.citation: Circ Res. 1999 Mar 19;84(5):562-70
references.pmid: 10082478
references.citation: Nucleic Acids Res. 2006 Jul 1;34(Web Server issue):W472-6
references.pmid: 16845052
references.citation: Bioinformatics. 2002 Jan;18(1):207-8
references.pmid: 11836235
references.citation: Circ Res. 1962 Mar;10:306-12
references.pmid: 13922328
references.citation: J Pharmacol Exp Ther. 2007 Apr;321(1):165-71
references.pmid: 17215446
references.citation: Mol Cell Biochem. 2005 Jan;268(1-2):103-10
references.pmid: 15724443
references.citation: J Am Coll Cardiol. 1997 Aug;30(2):576-84
references.pmid: 9247535
references.citation: Bioinformatics. 2004 Jun 12;20(9):1453-4
references.pmid: 14871861
references.citation: J Mol Cell Cardiol. 2006 Jan;40(1):76-86
references.pmid: 16236311
references.citation: Mol Cell Biochem. 1997 Dec;177(1-2):61-7
references.pmid: 9450646
references.citation: Circulation. 1992 Apr;85(4):1464-72
references.pmid: 1555287
references.citation: Am J Physiol Heart Circ Physiol. 2007 Aug;293(2):H1223-30
references.pmid: 17434978
references.citation: Genomics. 2004 Feb;83(2):281-97
references.pmid: 14706457
references.citation: Circ Res. 2004 Oct 1;95(7):717-25
references.pmid: 15345654
references.citation: Circ Res. 1999 Mar 19;84(5):571-86
references.pmid: 10082479
references.citation: Circ Res. 1996 Feb;78(2):262-73
references.pmid: 8575070
references.citation: Cardiovasc Res. 2001 Oct;52(1):103-10
references.pmid: 11557238
references.citation: Nat Genet. 2000 May;25(1):25-9
references.pmid: 10802651
references.citation: J Am Coll Cardiol. 2006 Oct 17;48(8):1610-7
references.pmid: 17045896
references.citation: Circulation. 1999 Nov 16;100(20):2113-8
references.pmid: 10562269
references.citation: Cardiovasc Res. 1999 May;42(2):270-83
references.pmid: 10533566
references.citation: Electrophoresis. 1998 Aug;19(11):2021-30
references.pmid: 9740064
references.citation: Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5116-21
references.pmid: 11309499
references.citation: J Biol Chem. 1992 Mar 15;267(8):5317-23
references.pmid: 1312087
references.citation: Rev Cardiovasc Med. 2003;4 Suppl 2:S14-20
references.pmid: 12776009
references.citation: Physiol Genomics. 2003 Jan 15;12(2):97-112
references.pmid: 12429867
references.citation: Am J Physiol Heart Circ Physiol. 2004 Sep;287(3):H1003-12
references.pmid: 15105169
references.citation: Circulation. 2002 Jul 23;106(4):423-9
references.pmid: 12135940
references.citation: Physiol Genomics. 2007 Mar 14;29(1):76-83
references.pmid: 17164392
references.citation: Am J Physiol Heart Circ Physiol. 2007 Dec;293(6):H3524-31
references.pmid: 17906102
references.citation: J Hypertens. 2006 Jun;24(6):1097-104
references.pmid: 16685210
references.citation: J Cardiovasc Pharmacol. 2007 Jun;49(6):408-15
references.pmid: 17577106